NR treatment not only reduced DAI scores, but also increased the expression of PGC1α and TFAM, as well as the activity of Complex I and II in mice undergoing experimental colitis, indicating that NR treatment increased the NAD+ levels within the colonocytes. This evidence concerns the gene PPARGC1A and colitis.